Latest News & Features
Generics
The US Court of Appeals for the Federal Circuit has affirmed US Patent Trial and Appeal Board’s decisions upholding three patents related to Teva Pharmaceutical’s migraine drug Ajovy, but has invalidated six others. 19 August 2021
Americas
Nexus Pharmaceuticals and rival Nevakar have gone to court to determine which company has the right to sell a new hypotension drug, which can be administered to patients under anesthesia during surgery. 19 August 2021
Generics
The US Court of Appeals for the Federal Circuit has affirmed a Delaware court ruling upholding the validity of cancer drug patents owned by Teva Pharmaceuticals. 17 August 2021
Americas
Mylan Laboratories has urged the US Supreme Court to overturn the controversial NHK-Fintiv rule, claiming that it is “unlawful”. 16 August 2021
Big Pharma
A Delaware magistrate judge has said that Roche subsidiaries should not be able to dismiss a suit claiming they infringed two DNA patents. 12 August 2021
Americas
Zimmer Biomet is suing rival dental implant manufacturer Integrated Dental Systems, claiming that it markets “cheap” replacement parts for Zimmer’s implant systems. 12 August 2021
Americas
The Brazilian Senate Plenary has approved a bill that will allow President Bolsonaro to waive patent protections for COVID-19 vaccines. 12 August 2021
article
When the smallest error in translation can result in a patent’s rejection or invalidation, it is important to be mindful of the key steps to successfully translate a patent and the impact it can have if they are not considered. 12 August 2021
Americas
The US Court of Appeals for the Federal Circuit has reinstated a $235 million verdict against Teva in a split decision which could have major implications for skinny label generics. 10 August 2021
Medtech
The US Court of Appeals for the Seventh Circuit has upheld a preliminary injunction from an Illinois court that blocked medical device maker Aegis Spine from selling its spinal implant. 10 August 2021